Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Hackensack NJ, New York NY, Philadelphia PA,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase1, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Hackensack NJ, New York NY, New Hyde Park NY,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase3, Recruiting
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Hackensack NJ, Baltimore MD, Washington D.C. DC,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT07110246
Phase2, Recruiting
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: Hackensack NJ, The Bronx NY, New York NY, Plainsboro NJ,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome
for
NAS
Location: Hackensack NJ, New York NY, Valhalla NY,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 0+
Code: NCT03533985
Recruiting
Pancreatic Cancer Early Detection Consortium
for
Pancreas Cancer, Pancreas Cyst,
Location: Hackensack NJ, New York NY, White Plains NY,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 18 - 70+
Code: NCT04970056
Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Hackensack NJ, New Haven CT, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase1, Phase2, Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Hackensack NJ, New York NY, Philadelphia PA, Boston MA,
Sponsor: K36 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05651932
Phase1, Recruiting
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
for
Peripheral T-cell Lymphoma
Location: Hackensack NJ, Greenville SC, Louisville KY, Atlanta GA,
Sponsor: CerRx, Inc.
Sex: All
Age: 18+
Code: NCT02495415
Phase2, Recruiting
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
for
Alzheimer Disease
Location: Hackensack NJ
Sponsor: Herrick Medical LLC
Sex: All
Age: 50 - 70+
Code: NCT05295615
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for
Functional Mitral Regurgitation, Heart Failure,
Location: Edison NJ, Newark NJ, New York NY, Poughkeepsie NY,
Sponsor: Cardiac Dimensions, Inc.
Sex: All
Age: 18+
Code: NCT03142152
Recruiting
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
for
Lupus Nephritis
Location: Hackensack NJ, New York NY, Akron OH, Cleveland OH,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 8 - 20
Code: NCT05538208
Phase2, Recruiting
First in Human, Dose Escalation Study of AN4005
for
Advanced Solid Tumor, Advanced Lymphoma
Location: Hackensack NJ, The Bronx NY, Fairfax VA, Greenville SC
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT04999384
Phase1, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants